Cardlytics (CDLX) Stock Price, News & Analysis

Company Overview

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

Key Stats

• Today's Range: $1.85 to $2.01
• 50-Day Range: $1.23 to $2.48
• 52-Week Range: $1.22 to $10.01
• Volume: 678,070 shs
• Average Volume: 991,425 shs
• Market Capitalization: $100.96 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.20
• Consensus Rating: Hold

Cardlytics Stock Analysis - MarketRank™

Cardlytics scored higher than 67% of companies evaluated by MarketBeat, and ranked 119th out of 325 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Hold

Consensus Rating

Cardlytics has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no buy ratings, 5 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Cardlytics has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cardlytics is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cardlytics is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cardlytics has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

17.12% of the float of Cardlytics has been sold short.

Short Interest Ratio / Days to Cover

Cardlytics has a short interest ratio ("days to cover") of 8.2.

Change versus previous month

Short interest in Cardlytics has recently increased by 1.96%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cardlytics does not currently pay a dividend.

Dividend Growth

Cardlytics does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 2.8 / 5
• Environmental Score: -0.67

Percentage of Shares Shorted

17.12% of the float of Cardlytics has been sold short.

Short Interest Ratio / Days to Cover

Cardlytics has a short interest ratio ("days to cover") of 8.2.

Change versus previous month

Short interest in Cardlytics has recently increased by 1.96%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.82

News Sentiment

Cardlytics has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Cardlytics this week, compared to 5 articles on an average week.

Search Interest

Only 1 people have searched for CDLX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

1 people have added Cardlytics to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $244,017.00 in company stock.

Percentage Held by Insiders

Only 4.40% of the stock of Cardlytics is held by insiders.

Percentage Held by Institutions

68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CDLX Stock Analysis - Frequently Asked Questions

How have CDLX shares performed this year?

Cardlytics' stock was trading at $3.71 at the beginning of the year. Since then, CDLX shares have decreased by 47.8% and is now trading at $1.9350.
View the best growth stocks for 2025 here.

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) released its earnings results on Wednesday, November, 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.33) by $0.18. The firm's revenue was down 15.1% compared to the same quarter last year.
Read the conference call transcript.

Does Cardlytics have any subsidiaries?

Cardlytics subsidiaries include these companies: Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

When did Cardlytics IPO?

Cardlytics (CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Who are Cardlytics' major shareholders?

Top institutional investors of Cardlytics include LPL Financial LLC (1.65%), Lane Generational LLC (1.17%), Charles Schwab Investment Management Inc. (0.65%) and Brooktree Capital Management (0.43%). Insiders that own company stock include Clifford Sosin, Amit Gupta, Karim Saad Temsamani, Lynne Marie Laube, Scott D Grimes, Alexis Desieno, Nicholas Hollmeyer Lynton, Andrew Christiansen, John V Balen and Kirk Somers.
View institutional ownership trends.

How do I buy shares of Cardlytics?

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 5/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Computer programming, data processing, & other computer related
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:CDLX
• CIK: 1666071
• Web: www.cardlytics.com
• Phone: (888) 798-5802
• Fax: N/A
• Employees: 500
• Year Founded: 2008

Price Target and Rating

• Average Stock Price Target: $5.20
• High Stock Price Target: $12.00
• Low Stock Price Target: $2.50
• Potential Upside/Downside: +168.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.14
• Research Coverage: 7 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($3.86)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-134,700,000.00
• Net Margins: -93.55%
• Pretax Margin: -93.55%
• Return on Equity: -110.67%
• Return on Assets: -32.70%

Debt

• Debt-to-Equity Ratio: 2.40
• Current Ratio: 1.18
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $278.30 million
• Price / Sales: 0.36
• Cash Flow: $0.82 per share
• Price / Cash Flow: 2.36
• Book Value: $3.43 per share
• Price / Book: 0.56

Miscellaneous

• Outstanding Shares: 52,174,000
• Free Float: 48,586,000
• Market Cap: $100.96 million
• Optionable: Optionable
• Beta: 1.30